Catalyst Wire Dossier Catalyst Wire Dossier

Tiotropium/olodaterol fixed-dose combination

tiotropium/olodaterol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Tiotropium/olodaterol fixed-dose combination, covering 2018-08-17 to 2023-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greece

See pricing